| Literature DB >> 28638185 |
Abstract
Performing a literature search is an important part of performing a systematic review or a meta-analysis of biomedical literature, which have now become the gold standards for determining what qualifies as 'evidence-based' medicine. Combining searches of English-language databases and the large Chinese-language databases can identify new, potentially important, sources of data that are not include in the traditional English-only reviews. Selection of a restricted subset of databases for conducting the literature search or using inappropriate methods to identify appropriate articles within each database can lead to biased results and incorrect conclusions. This article introduces common English and Chinese databases, describes the search engines available for conducting searches, discusses the basic methods and common pitfalls of conducting searches, and provides an example of a search to highlight these issues.Entities:
Keywords: bibliography; databases; literature review; meta-analysis; publication bias; systematic review
Year: 2016 PMID: 28638185 PMCID: PMC5434301 DOI: 10.11919/j.issn.1002-0829.215008
Source DB: PubMed Journal: Shanghai Arch Psychiatry ISSN: 1002-0829
Comparisons of commonly used English and Chinese databases
| database | field | geographic | subject heading |
|---|---|---|---|
| MEDLINE | medicine, pharmacology, and nursing | global with a focus on North America | MeSH |
| EMBASE | medicine, public health, and pharmacology | global with a focus on Europe | Emtree |
| PsycINFO | psychology and psychiatry | global | Descriptors |
| CINAHL | nursing and health care | global | CINAHL Headings |
| LILACS | medicine, public health, pharmacology, and nursing | Latin America and the Caribbean | DeCS |
| SINOMED | medicine, public health, pharmacology, traditional Chinese medicine, and nursing | mainland China | MeSH, traditional Chinese medicine headings |
| CENTRAL | clinical trials | global | MeSH |
The PICOS tool
| PICOS | key question |
|---|---|
| patients/problems (P) | Who are the patients or what are their problems (e.g., main health conditions, comorbid conditions, and other clinically significant characteristics)? |
| intervention (I) | What is the intervention under consideration (e.g. diagnosis, treatment, or prognosis-related factor)? |
| comparison (C) | Is there a standard intervention to compare with? |
| outcome (O) | What are the ultimate goals of the intervention? |
| study design (S) | What is the study design or the intervention protocol? |
An example of PICOS search strategy
| P (Schizophrenia) | I (Perazine) | S (RCT) |
|---|---|---|
| #1 schizophren* | #5 perazin* | #12 randomized controlled trial[pt] |
| #2 dementia Praecox | #6 taxilan* | #13 controlled clinical trial[pt] |
| #3 exp schizophrenia[Mesh] | #7 pernazin* | #14 randomized [tiab] |
| #4 or 1/3 | #8 piperazin* | #15 placebo [tiab] |
| #9 phenothiazine tranquilizer* | #16 randomly [tiab] | |
| #10 perazine[Mesh] | #17 trial [tiab] | |
| #11 or 5/10 | #18 groups [tiab] | |
| #19 or 11/17 | ||
| #20 animals [MeSh] not human [MeSh] | ||
| #21 #19 not #20 | ||
Analysis showing the cross coverage of search results for different types of studies using the 4 different Chinese-language databases
| search for clinical intervention studies[ | search for risk factor studies[ | ||
|---|---|---|---|
| TOTAL NUMBER OF UNIQUE ARTICLES IDENTIFIED | |||
| SinoMed | 983(79.98°%) | 73(65.18%) | |
| CNKI | 407(33.12%%) | 63(56.25%) | |
| Wanfang | 464(37.75%) | 69(61.61%) | |
| Chongqing VIP | 492(40.03%) | 65(58.04%) | |
| SinoMed+CNKI | 1027(83.56%) | 93(83.04%) | |
| SinoMed+Wanfang | 1061(86.33%) | 91(81.25%) | |
| SinoMed+Chongqing VIP | 1130(91.94%) | 88(78.57%) | |
| CNKI+Wanfang | 517(42.88%) | 89(79.46%) | |
| CNKI+Chongqing VIP | 527(42.88%) | 85(75.89%) | |
| Wanfang+Chongqing VIP | 553(45.00%) | 84(75.00%) | |
| SinoMed+CNKI+Wanfang | 1080(87.88%) | 104(92.86%) | |
| SinoMed+CNKI+Chongqing VIP | 1091(88.77%) | 102(91.07%) | |
| SinoMed+Wanfang+Chongqing VIP | 1107(90.07%) | 101(90.18%) | |
| CNKI+Wanfang+Chongqing VIP | 659(53.62%) | 98(87.50%) | |
a search for articles about randomized controlled trials (RCTs) for depression using any antidepressant versus placebo
b search for case-control studies about risk factors for suicide or suicide attempt